EL DORADO HILLS, Calif.--(BUSINESS WIRE)--April 15, 2004--NutraCea (OTCBB:NTRZ), a leading nutraceutical research and development company, announced today that it expects to file its Form 10KSB (Annual Report) with the Securities and Exchange Commission at the completion of its audit.
"This annual report will reflect numerous changes and improvements in preparation for introducing our products globally", said John Howell, President and COO. "We appreciate our shareholder's patience during this process and temporary delay."
NutraCea is the company behind revolutionary nutraceutical products that are safe, non-toxic and all-natural, which the company believes may provide it with a competitive edge over traditional pharmaceutical solutions. The company has conducted scientific research to discover how the nutrients in its products help the human body heal itself. The results from limited clinical trials are astonishing: NutraCea's products may provide significant relief for type 1 and type 2 diabetes by lowering blood glucose levels. They may also impact various cardiovascular diseases by lowering cholesterol, triglyceride and apolipoprotein B levels. The company's products may also help the body maximize health by normalizing weight and metabolism as well as enhancing liver and immune functions.
NutraCea doesn't expect to become a serious challenger for existing pharmaceutical solutions. However, the company's goal is to become the market leader in the all-natural and non-toxic nutraceutical segment of the overall market.
NutraCea's breakthrough nutraceutical products consist of stabilized rice bran derivatives. Rice bran is the most potent source of phytonutrients and antioxidants found in any food today. Unfortunately, it has been unusable for human consumption in the past because an enzyme in the brown rice kernel renders the bran rancid within hours of milling. NutraCea's products retain the vital nutrients of rice bran in a uniquely bioavailable form due to a major breakthrough in advanced processing technology. The company has subsequently launched a wide variety of nutraceutical products based on stabilized rice bran.
To learn more about NutraCea's products, visit http://www.nutraceacorp.com. To sign up for shareholder alerts, visit http://www.nutraceacorp.com/ir_alerts.html or simply send an email to alerts@nutraceacorp.com. For a shareholder package, visit http://www.nutraceacorp.com/ir_iik.html.
The matters set forth in this press release are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks are detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission including the company's Annual Report, Quarterly Reports and other periodic filings. These forward-looking statements speak only as of the date hereof. The company disclaims any intent or obligation to update these forward-looking statements. FDA Health Disclaimer: NutraCea's product related statements have not been evaluated by the Food and Drug Administration. The company's products are not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before using any nutraceutical products.
Contacts
NutraCea Corporation Edward Newton, 916-933-7000 (Investor Relations) or
Arthur Douglas and Associates, Inc. Jeffrey Kahler, 407-478-1120 ext. 250 or
Adelman Communications (Media Relations) Margie Adelman, 561-347-6768 or 561-866-2215 (cell)